Global OTC Anti-Infective Medicine Market Growth (Status and Outlook) 2022-2028
Anti-infectives are medicines that work to prevent or treat infections, they include antibacterials, antivirals, antifungals and antiparasitic medications.
The global market for OTC Anti-Infective Medicine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC OTC Anti-Infective Medicine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States OTC Anti-Infective Medicine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe OTC Anti-Infective Medicine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China OTC Anti-Infective Medicine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key OTC Anti-Infective Medicine players cover GlaxoSmithKline, Merck, Pfizer, Novartis and Abbott, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global OTC Anti-Infective Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global OTC Anti-Infective Medicine market, with both quantitative and qualitative data, to help readers understand how the OTC Anti-Infective Medicine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the OTC Anti-Infective Medicine market and forecasts the market size by Type (Antibacterials Medicine, Antivirals Medicine and Antifungals Medicine), by Application (Hospital and Retail Pharmacy.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Antibacterials Medicine
Antivirals Medicine
Antifungals Medicine
Antiparasitic Medicine
Segmentation by application
Hospital
Retail Pharmacy
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
Chapter Introduction
Chapter 1: Scope of OTC Anti-Infective Medicine, Research Methodology, etc.
Chapter 2: Executive Summary, global OTC Anti-Infective Medicine market size and CAGR, OTC Anti-Infective Medicine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: OTC Anti-Infective Medicine revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global OTC Anti-Infective Medicine revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global OTC Anti-Infective Medicine market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including GlaxoSmithKline, Merck, Pfizer, Novartis, Abbott, Sanofi, Bristol-Myers Squibb and Roche, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global OTC Anti-Infective Medicine Market Size 2017-2028
2.1.2 OTC Anti-Infective Medicine Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 OTC Anti-Infective Medicine Segment by Type
2.2.1 Antibacterials Medicine
2.2.2 Antivirals Medicine
2.2.3 Antifungals Medicine
2.2.4 Antiparasitic Medicine
2.3 OTC Anti-Infective Medicine Market Size by Type
2.3.1 OTC Anti-Infective Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global OTC Anti-Infective Medicine Market Size Market Share by Type (2017-2022)
2.4 OTC Anti-Infective Medicine Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.5 OTC Anti-Infective Medicine Market Size by Application
2.5.1 OTC Anti-Infective Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global OTC Anti-Infective Medicine Market Size Market Share by Application (2017-2022)
3 OTC Anti-Infective Medicine Market Size by Player
3.1 OTC Anti-Infective Medicine Market Size Market Share by Players
3.1.1 Global OTC Anti-Infective Medicine Revenue by Players (2020-2022)
3.1.2 Global OTC Anti-Infective Medicine Revenue Market Share by Players (2020-2022)
3.2 Global OTC Anti-Infective Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OTC Anti-Infective Medicine by Regions
4.1 OTC Anti-Infective Medicine Market Size by Regions (2017-2022)
4.2 Americas OTC Anti-Infective Medicine Market Size Growth (2017-2022)
4.3 APAC OTC Anti-Infective Medicine Market Size Growth (2017-2022)
4.4 Europe OTC Anti-Infective Medicine Market Size Growth (2017-2022)
4.5 Middle East & Africa OTC Anti-Infective Medicine Market Size Growth (2017-2022)
5 Americas
5.1 Americas OTC Anti-Infective Medicine Market Size by Country (2017-2022)
5.2 Americas OTC Anti-Infective Medicine Market Size by Type (2017-2022)
5.3 Americas OTC Anti-Infective Medicine Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC Anti-Infective Medicine Market Size by Region (2017-2022)
6.2 APAC OTC Anti-Infective Medicine Market Size by Type (2017-2022)
6.3 APAC OTC Anti-Infective Medicine Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe OTC Anti-Infective Medicine by Country (2017-2022)
7.2 Europe OTC Anti-Infective Medicine Market Size by Type (2017-2022)
7.3 Europe OTC Anti-Infective Medicine Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa OTC Anti-Infective Medicine by Region (2017-2022)
8.2 Middle East & Africa OTC Anti-Infective Medicine Market Size by Type (2017-2022)
8.3 Middle East & Africa OTC Anti-Infective Medicine Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global OTC Anti-Infective Medicine Market Forecast
10.1 Global OTC Anti-Infective Medicine Forecast by Regions (2023-2028)
10.1.1 Global OTC Anti-Infective Medicine Forecast by Regions (2023-2028)
10.1.2 Americas OTC Anti-Infective Medicine Forecast
10.1.3 APAC OTC Anti-Infective Medicine Forecast
10.1.4 Europe OTC Anti-Infective Medicine Forecast
10.1.5 Middle East & Africa OTC Anti-Infective Medicine Forecast
10.2 Americas OTC Anti-Infective Medicine Forecast by Country (2023-2028)
10.2.1 United States OTC Anti-Infective Medicine Market Forecast
10.2.2 Canada OTC Anti-Infective Medicine Market Forecast
10.2.3 Mexico OTC Anti-Infective Medicine Market Forecast
10.2.4 Brazil OTC Anti-Infective Medicine Market Forecast
10.3 APAC OTC Anti-Infective Medicine Forecast by Region (2023-2028)
10.3.1 China OTC Anti-Infective Medicine Market Forecast
10.3.2 Japan OTC Anti-Infective Medicine Market Forecast
10.3.3 Korea OTC Anti-Infective Medicine Market Forecast
10.3.4 Southeast Asia OTC Anti-Infective Medicine Market Forecast
10.3.5 India OTC Anti-Infective Medicine Market Forecast
10.3.6 Australia OTC Anti-Infective Medicine Market Forecast
10.4 Europe OTC Anti-Infective Medicine Forecast by Country (2023-2028)
10.4.1 Germany OTC Anti-Infective Medicine Market Forecast
10.4.2 France OTC Anti-Infective Medicine Market Forecast
10.4.3 UK OTC Anti-Infective Medicine Market Forecast
10.4.4 Italy OTC Anti-Infective Medicine Market Forecast
10.4.5 Russia OTC Anti-Infective Medicine Market Forecast
10.5 Middle East & Africa OTC Anti-Infective Medicine Forecast by Region (2023-2028)
10.5.1 Egypt OTC Anti-Infective Medicine Market Forecast
10.5.2 South Africa OTC Anti-Infective Medicine Market Forecast
10.5.3 Israel OTC Anti-Infective Medicine Market Forecast
10.5.4 Turkey OTC Anti-Infective Medicine Market Forecast
10.5.5 GCC Countries OTC Anti-Infective Medicine Market Forecast
10.6 Global OTC Anti-Infective Medicine Forecast by Type (2023-2028)
10.7 Global OTC Anti-Infective Medicine Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline OTC Anti-Infective Medicine Product Offered
11.1.3 GlaxoSmithKline OTC Anti-Infective Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck OTC Anti-Infective Medicine Product Offered
11.2.3 Merck OTC Anti-Infective Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer OTC Anti-Infective Medicine Product Offered
11.3.3 Pfizer OTC Anti-Infective Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis OTC Anti-Infective Medicine Product Offered
11.4.3 Novartis OTC Anti-Infective Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Abbott
11.5.1 Abbott Company Information
11.5.2 Abbott OTC Anti-Infective Medicine Product Offered
11.5.3 Abbott OTC Anti-Infective Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Abbott Main Business Overview
11.5.5 Abbott Latest Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi OTC Anti-Infective Medicine Product Offered
11.6.3 Sanofi OTC Anti-Infective Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Sanofi Main Business Overview
11.6.5 Sanofi Latest Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Information
11.7.2 Bristol-Myers Squibb OTC Anti-Infective Medicine Product Offered
11.7.3 Bristol-Myers Squibb OTC Anti-Infective Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bristol-Myers Squibb Main Business Overview
11.7.5 Bristol-Myers Squibb Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche OTC Anti-Infective Medicine Product Offered
11.8.3 Roche OTC Anti-Infective Medicine Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. OTC Anti-Infective Medicine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Antibacterials Medicine
Table 3. Major Players of Antivirals Medicine
Table 4. Major Players of Antifungals Medicine
Table 5. Major Players of Antiparasitic Medicine
Table 6. OTC Anti-Infective Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global OTC Anti-Infective Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global OTC Anti-Infective Medicine Market Size Market Share by Type (2017-2022)
Table 9. OTC Anti-Infective Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global OTC Anti-Infective Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global OTC Anti-Infective Medicine Market Size Market Share by Application (2017-2022)
Table 12. Global OTC Anti-Infective Medicine Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global OTC Anti-Infective Medicine Revenue Market Share by Player (2020-2022)
Table 14. OTC Anti-Infective Medicine Key Players Head office and Products Offered
Table 15. OTC Anti-Infective Medicine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global OTC Anti-Infective Medicine Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global OTC Anti-Infective Medicine Market Size Market Share by Regions (2017-2022)
Table 20. Americas OTC Anti-Infective Medicine Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas OTC Anti-Infective Medicine Market Size Market Share by Country (2017-2022)
Table 22. Americas OTC Anti-Infective Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas OTC Anti-Infective Medicine Market Size Market Share by Type (2017-2022)
Table 24. Americas OTC Anti-Infective Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas OTC Anti-Infective Medicine Market Size Market Share by Application (2017-2022)
Table 26. APAC OTC Anti-Infective Medicine Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC OTC Anti-Infective Medicine Market Size Market Share by Region (2017-2022)
Table 28. APAC OTC Anti-Infective Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC OTC Anti-Infective Medicine Market Size Market Share by Type (2017-2022)
Table 30. APAC OTC Anti-Infective Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC OTC Anti-Infective Medicine Market Size Market Share by Application (2017-2022)
Table 32. Europe OTC Anti-Infective Medicine Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe OTC Anti-Infective Medicine Market Size Market Share by Country (2017-2022)
Table 34. Europe OTC Anti-Infective Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe OTC Anti-Infective Medicine Market Size Market Share by Type (2017-2022)
Table 36. Europe OTC Anti-Infective Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe OTC Anti-Infective Medicine Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa OTC Anti-Infective Medicine Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa OTC Anti-Infective Medicine Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa OTC Anti-Infective Medicine Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa OTC Anti-Infective Medicine Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa OTC Anti-Infective Medicine Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa OTC Anti-Infective Medicine Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of OTC Anti-Infective Medicine
Table 45. Key Market Challenges & Risks of OTC Anti-Infective Medicine
Table 46. Key Industry Trends of OTC Anti-Infective Medicine
Table 47. Global OTC Anti-Infective Medicine Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global OTC Anti-Infective Medicine Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global OTC Anti-Infective Medicine Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global OTC Anti-Infective Medicine Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global OTC Anti-Infective Medicine Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global OTC Anti-Infective Medicine Market Size Market Share Forecast by Application (2023-2028)
Table 53. GlaxoSmithKline Details, Company Type, OTC Anti-Infective Medicine Area Served and Its Competitors
Table 54. GlaxoSmithKline OTC Anti-Infective Medicine Product Offered
Table 55. GlaxoSmithKline OTC Anti-Infective Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. GlaxoSmithKline Main Business
Table 57. GlaxoSmithKline Latest Developments
Table 58. Merck Details, Company Type, OTC Anti-Infective Medicine Area Served and Its Competitors
Table 59. Merck OTC Anti-Infective Medicine Product Offered
Table 60. Merck Main Business
Table 61. Merck OTC Anti-Infective Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Merck Latest Developments
Table 63. Pfizer Details, Company Type, OTC Anti-Infective Medicine Area Served and Its Competitors
Table 64. Pfizer OTC Anti-Infective Medicine Product Offered
Table 65. Pfizer Main Business
Table 66. Pfizer OTC Anti-Infective Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Pfizer Latest Developments
Table 68. Novartis Details, Company Type, OTC Anti-Infective Medicine Area Served and Its Competitors
Table 69. Novartis OTC Anti-Infective Medicine Product Offered
Table 70. Novartis Main Business
Table 71. Novartis OTC Anti-Infective Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Novartis Latest Developments
Table 73. Abbott Details, Company Type, OTC Anti-Infective Medicine Area Served and Its Competitors
Table 74. Abbott OTC Anti-Infective Medicine Product Offered
Table 75. Abbott Main Business
Table 76. Abbott OTC Anti-Infective Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Abbott Latest Developments
Table 78. Sanofi Details, Company Type, OTC Anti-Infective Medicine Area Served and Its Competitors
Table 79. Sanofi OTC Anti-Infective Medicine Product Offered
Table 80. Sanofi Main Business
Table 81. Sanofi OTC Anti-Infective Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Sanofi Latest Developments
Table 83. Bristol-Myers Squibb Details, Company Type, OTC Anti-Infective Medicine Area Served and Its Competitors
Table 84. Bristol-Myers Squibb OTC Anti-Infective Medicine Product Offered
Table 85. Bristol-Myers Squibb Main Business
Table 86. Bristol-Myers Squibb OTC Anti-Infective Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Bristol-Myers Squibb Latest Developments
Table 88. Roche Details, Company Type, OTC Anti-Infective Medicine Area Served and Its Competitors
Table 89. Roche OTC Anti-Infective Medicine Product Offered
Table 90. Roche Main Business
Table 91. Roche OTC Anti-Infective Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Roche Latest Developments
List of Figures
List of Figures
Figure 1. OTC Anti-Infective Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global OTC Anti-Infective Medicine Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global OTC Anti-Infective Medicine Market Size Market Share by Type in 2021
Figure 7. OTC Anti-Infective Medicine in Hospital
Figure 8. Global OTC Anti-Infective Medicine Market: Hospital (2017-2022) & ($ Millions)
Figure 9. OTC Anti-Infective Medicine in Retail Pharmacy
Figure 10. Global OTC Anti-Infective Medicine Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 11. Global OTC Anti-Infective Medicine Market Size Market Share by Application in 2021
Figure 12. Global OTC Anti-Infective Medicine Revenue Market Share by Player in 2021
Figure 13. Global OTC Anti-Infective Medicine Market Size Market Share by Regions (2017-2022)
Figure 14. Americas OTC Anti-Infective Medicine Market Size 2017-2022 ($ Millions)
Figure 15. APAC OTC Anti-Infective Medicine Market Size 2017-2022 ($ Millions)
Figure 16. Europe OTC Anti-Infective Medicine Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa OTC Anti-Infective Medicine Market Size 2017-2022 ($ Millions)
Figure 18. Americas OTC Anti-Infective Medicine Value Market Share by Country in 2021
Figure 19. Americas OTC Anti-Infective Medicine Consumption Market Share by Type in 2021
Figure 20. Americas OTC Anti-Infective Medicine Market Size Market Share by Application in 2021
Figure 21. United States OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC OTC Anti-Infective Medicine Market Size Market Share by Region in 2021
Figure 26. APAC OTC Anti-Infective Medicine Market Size Market Share by Application in 2021
Figure 27. China OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 31. India OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe OTC Anti-Infective Medicine Market Size Market Share by Country in 2021
Figure 34. Europe OTC Anti-Infective Medicine Market Size Market Share by Type in 2021
Figure 35. Europe OTC Anti-Infective Medicine Market Size Market Share by Application in 2021
Figure 36. Germany OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 37. France OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa OTC Anti-Infective Medicine Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa OTC Anti-Infective Medicine Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa OTC Anti-Infective Medicine Market Size Market Share by Application in 2021
Figure 44. Egypt OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country OTC Anti-Infective Medicine Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 50. APAC OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 51. Europe OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 53. United States OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 54. Canada OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 55. Mexico OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 56. Brazil OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 57. China OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 58. Japan OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 59. Korea OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 61. India OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 62. Australia OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 63. Germany OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 64. France OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 65. UK OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 66. Italy OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 67. Russia OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 68. Spain OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 69. Egypt OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 70. South Africa OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 71. Israel OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 72. Turkey OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries OTC Anti-Infective Medicine Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets